Inhibitory effects of iron on bone morphogenetic protein 2–induced osteoblastogenesis
Open accessThe DOI matches its Crossref record; 7 of the 7 references it cites were found in a registry or an index.
Abstract
Postmenopausal osteoporosis is characterized by an imbalance of bone resorption exceeding bone formation, resulting in a net loss of bone mineral density (BMD). Estrogen deficiency is known to promote bone resorption. However, the causative factors that impair bone formation have not been identified. Women after menopause experience not only estrogen deficiency but also iron accumulation as a result of cessation of menstruation. In this study we investigated whether increased iron plays a role in osteoporosis. By growing primary mouse osteoclast and osteoblast progenitor cells as well as immortalized cell lines in the presence of iron, we found that increased iron had minimal effects on osteoclast cell differentiation. Interestingly, iron, particularly in its inorganic form, and to a lesser extent ferritin and transferrin all suppressed alkaline phosphatase (ALP) activities in osteoblasts. Moreover, iron downregulated mRNA levels of several other osteoblastogenic markers such as Runx2, osterix, osteopontin, and osteocalcin. To further show that this in vitro finding is relevant to the in vivo condition, we demonstrated that iron-accumulated mice with intact ovaries exhibited a significant decrease in BMD. Although iron inhibited preosteoblast cell differentiation, it did enhance preosteoblast cell proliferation, as evidenced by increased cell growth and expression of cell cycle regulator genes such as CDK4, CDK6, cyclin D1, and cyclin D3 and G2/M phase cell population. Taken together, our results suggest that increased iron could be a factor that slows down bone formation in postmenopausal women. © 2011 American Society for Bone and Mineral Research.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Nakashima, K., Zhou, X., Kunkel, G., Zhang, Z., Deng, J. M., Behringer, R. R., & de Crombrugghe, B. (2002) · Cell · doi:10.1016/s0092-8674(01)00622-5 · Cited by 3,608 · cited 1×
“Osterix is another prerequisite transcription factor for preosteoblast differentiation,((31)) and its expression is also induced by BMP treatment in immature mesenchymal cell lines.((32)) Our results demonstrated that iron pretreatment significantly blocked BMP-2-induced expression of Runx2 and osterix.”
BackgroundPathogenesis of osteoporosis: concepts, conflicts, and prospects
Raisz, L. G. (2005) · Journal of Clinical Investigation · doi:10.1172/jci27071 · Cited by 1,779 · cited 1×
“Although it is well known how bone resorption is stimulated by estrogen deficiency,((20)) factors that impair bone formation have not yet been identified.”
BackgroundZimmermann, M. B., & Hurrell, R. F. (2007) · The Lancet · doi:10.1016/s0140-6736(07)61235-5 · Cited by 1,405
Postmenopausal Hormone Replacement Therapy: Scientific Review
Nelson, H. D., Humphrey, L. L., Nygren, P., Teutsch, S. M., & Allan, J. D. (2002) · JAMA · doi:10.1001/jama.288.7.872 · Cited by 990 · cited 1×
“Conversely, estrogen deficiency has been considered the major cause of menopausal symptoms and diseases such as osteoporosis.((43)) Iron deficiency is a health problem long recognized by the medical community.”
BackgroundCoordination of PGC-1β and iron uptake in mitochondrial biogenesis and osteoclast activation
Ishii, K.-A., Fumoto, T., Iwai, K., Takeshita, S., Ito, M., Shimohata, N., Aburatani, H., Taketani, S., Lelliott, C. J., Vidal-Puig, A., et al. (2009) · Nature Medicine · doi:10.1038/nm.1910 · Cited by 410
Mechanisms of sex steroid effects on bone
Syed, F., & Khosla, S. (2005) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2004.11.097 · Cited by 380
Excess iron inhibits osteoblast metabolism
Yamasaki, K., & Hagiwara, H. (2009) · Toxicology Letters · doi:10.1016/j.toxlet.2009.08.023 · Cited by 168
Cited by
Hou, Y., Zhang, S., Wang, L., Li, J., Qu, G., He, J., Rong, H., Ji, H., & Liu, S. (2012) · Gene · doi:10.1016/j.gene.2012.09.060 · Cited by 210
“A variety of studies have demonstrated that extra iron burden would repress osteoblastogenesis, proliferation and mineralization (Messer et al., 2009; Yamasaki and Hagiwara, 2009; Yang et al., 2011), and enhance osteoclast differentiation and provoke osteoclastic function (Ishii et al.”
Background17β-Estradiol Inhibits Iron Hormone Hepcidin Through an Estrogen Responsive Element Half-Site
Yang, Q., Jian, J., Katz, S., Abramson, S. B., & Huang, X. (2012) · Endocrinology · doi:10.1210/en.2011-2045 · Cited by 208
Myostatin/Activin Receptor Ligands in Muscle and the Development Status of Attenuating Drugs
Rodgers, B. D., & Ward, C. W. (2022) · Endocrine Reviews · doi:10.1210/endrev/bnab030 · Cited by 111
Iron, Zinc, Copper, Cadmium, Mercury, and Bone Tissue
Ciosek, Ż., Kot, K., & Rotter, I. (2023) · International Journal of Environmental Research and Public Health · doi:10.3390/ijerph20032197 · Cited by 86
The regulation of iron metabolism by hepcidin contributes to unloading-induced bone loss
Xu, Z., Sun, W., Li, Y., Ling, S., Zhao, C., Zhong, G., Zhao, D., Song, J., Song, H., Li, J., et al. (2017) · Bone · doi:10.1016/j.bone.2016.09.023 · Cited by 76
“Increased iron and transferrin suppresses alkaline phosphatase activity in osteoblasts due to the higher oxidative stress [4].”
Background
Metadata
- Authors
- Yang, Q., Jian, J., Abramson, S. B., & Huang, X.
- Venue
- Journal of Bone and Mineral Research
- Publisher
- Oxford University Press (OUP)
- Published
- 2011-02-02
- Volume
- 26
- Issue
- 6
- Pages
- 1188-1196
- ISSN
- 0884-0431 (ISSN-L)
- 1523-4681
- OpenAlex
- W2032468674
- Cited by
- 127
- References
- 7
- FWCI
- 3.64
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Inhibitory effects of iron on bone morphogenetic protein 2–induced osteoblastogenesis. https://app.cochat.ai/papers/10.1002/jbmr.337
- The paper
- Yang, Q., Jian, J., Abramson, S. B., & Huang, X. (2011). Inhibitory effects of iron on bone morphogenetic protein 2–induced osteoblastogenesis. Journal of Bone and Mineral Research. https://doi.org/10.1002/jbmr.337
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.